Betashares Nasdaq 100 Etf

NDQ

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

Alcidion Group Limited

ALC

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. Its principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Its other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users. The firm services over 400 hospitals.

Appen Limited

APX

Appen Ltd. engages in the development of human-annotated datasets for machine learning and artificial intelligence. The company is headquartered in Chatswood, New South Wales and currently employs 1,475 full-time employees. The company went IPO on 2015-01-07. The firm is engaged in provision of data solutions and services for machine learning and artificial intelligence (AI). The firm operates through two segments: Global Services and New Markets. Global Services represents the services that the Company provides to its five United States technology customers (Global customers) using the customer's data annotation platforms and tools. New Markets comprises the Appen's data annotation platform and tools (Global Product), and the enterprise, government, and China business units. New Markets also includes Quadrant geolocation and Point-of-Interest (POI) data capabilities. Its Annotation Platform is the platform that both customers and internal teams use to design, run and manage data annotation tasks. The firm serves various industries including technology, automotive, financial services, healthcare, retail, and government agencies.

Archer Materials Limited

AXE

Archer Materials Ltd. is a materials technology company developing advanced semiconductor devices and processor chips related to quantum computing and medical diagnostics in Australia. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-08-14. The firm is developing advanced semiconductor devices, including chips relevant to quantum computing and medical diagnostics. The firm is progressing the development of its 12CQ quantum computing qubit processor chip (12CQ chip) and lab-on-a-chip biochip technology (biochip). The 12CQ chip is utilizing a carbon-based architecture that has the potential for practical qubit processing. The company is focused on advancing its 12CQ chip technology towards integration with mobile devices. Its biochip development involves integrating graphene with miniaturized lab-on-a-chip platforms for advanced medical diagnostics. The company is designing and building its biochip in clean-room facilities and engineering materials at the atom-scale. The company also develops its biochip for digitizing biologically relevant signals like those from viruses or bacteria.

iShares S&P 500 Etf

IVV

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.